In South Africa, HPV vaccination has been fully domestically financed since 2014 through a National Treasury conditional grant — without Gavi support — with provincial allocations rising from R49 million in 2024/25 to a projected R72 million in 2026/27. The programme transitioned to a single-dose schedule from 2023 and expanded to private and independent schools […]
Language: English
Context-responsive modelling to inform HPV vaccination strategies: from introduction, vaccine target expansion, to integration with screening
The IARC Public Health Decision Science Team presented a framework for context-responsive modelling across the full lifecycle of national HPV vaccination programs, from introduction through target expansion to integration with cervical screening. Using case studies from Bhutan, India, Sweden, and Rwanda, the team demonstrated how country-specific parameters — including disease burden, cost data, and coverage […]
Health Information Systems and Data for Action: Cameroon
In Cameroon, DHIS2 centralizes health data from approximately 6,000 health facilities, with monthly reporting cascading from facility to district, regional, and national levels. The presentation identifies five key gaps in the HPV health information system: limited integration of school registers into microplanning, absence of age-cohort disaggregation for catch-up targets, delayed and incomplete facility reporting, lack […]
Health Information Systems and Data for Action: Rwanda
In Rwanda, HPV vaccination data management has undergone a comprehensive transition from paper-based registers to integrated digital systems. Prior to 2022, health workers manually aggregated vaccination counts at month-end and reported them to HMIS, a process prone to human error, delays, and data fragmentation. Since 2020, the e-Tracker/DHIS2 system records individual client immunization data, enabling […]
Health Information Systems and Data for Action: Tanzania
In Tanzania, health information systems underpin the planning and monitoring of HPV vaccination across a country of over 67 million people and more than 12,000 health facilities. At the facility level, paper-based tools remain in use, while from the district upward, the Vaccine Information Management System (VIMS) consolidates routine immunization reporting, vaccine stock data, and […]
Panel Discussion on funding and financial sustainability
Global partners converged on a shared concern: development assistance for health is projected to fall by nearly 50% between 2021 and 2030, placing acute pressure on African countries where external funding covers more than a third — and in some cases more than half — of health expenditures. Gavi reaffirmed its commitment to HPV vaccination, […]
Country Action Plans – Plenary
Fifteen country delegations presented action plans centred on two converging priorities: securing sustainable domestic financing in anticipation of reduced external funding, and strengthening multisectoral coordination to reach out-of-school girls and hard-to-reach populations. Recurring commitments included advocacy to finance and education ministries, integration of HPV into school health platforms, and data system strengthening — with Tanzania, […]
Current Numbers: HPV disease prevalence and incidence across the AFRO region
Dr. Safdar Nosheen (WHO AFRO) presented critical epidemiological data at the 2025 CHIC Symposium, emphasizing that Africa bears a disproportionate burden of HPV-related diseases, with 18 of the 20 highest-burden countries globally located in the region. In sub-Saharan Africa, cervical cancer accounts for approximately 30% of female cancer diagnoses, with mortality rates reaching 23 per […]
HPV vaccine product landscape
Global HPV vaccine coverage stood at 28% of the female target population in 2024 despite 80% of WHO member states having introduced the vaccine, with the coverage gap driven by the delayed introduction of large-population countries including India, China, and Pakistan. The shift to single-dose schedules has fundamentally reshaped global demand dynamics: in 2024, a […]
Challenges and good practices for sustaining delivery after a MAC introduction: Nigeria’s experience towards cervical cancer elimination
In Nigeria, HPV vaccination was introduced in two phases — Phase 1 targeting 16 states (2023) and Phase 2 covering 21 additional states (October 2024) — with immediate routinization following each mass multi-age cohort (MAC) campaign. Combined MAC and routine delivery reached approximately 15.3 million girls aged 9–14 since introduction, with over 12.3 million vaccinated […]